TALi Digital (ASX:TD1)
About TALi
TALi is a pioneering digital therapeutic company developing solutions to assess, monitor and enhance cognitive function and treat cognitive impairment. TALi’s frontline solution addresses the unmet global need for early detection and safe treatment of attention deficits during early childhood. Our team of scientists, clinicians, developers and customer-focused individuals are on a mission to strengthen the attention of children globally, delivering lasting benefits in their cognitive development.
TALi Digital
TALi Health is a 100% owned subsidiary of TALi Digital Limited (ASX: TD1), which is an Australian medical technology company listed on the Australian Securities Exchange. TALi Digital’s core focus is the pioneering development of clinically-validated software solutions that assess and improve.
31/08/2022 17:14:00
HIGHLIGHTS
Total revenue and income $881,416
Net loss $5,830,004
Net cash at bank $1.85 million as at 30 June 2022
Strategic Licensing Agreement with global leader Akili …
